Results 131 to 140 of about 984,029 (267)

A Giant Basal Cell Carcinoma of the Scalp-A Clinical Case Study. [PDF]

Diagnostics (Basel)
Zagórska B, Rutkowski J, Kunc M, Żółkiewicz J, Maińska U, Sobjanek M, Sławińska M.   +6 more
europepmc   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

Molecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan, Irina Primac, Emre Etlioglu, Laurens Debruyne, Ann Janssen, Magy Sallam, Kevin Tabury, Roel Quintens, Wiebren Tjalma, Mohammed Abderrafi Benotmane   +9 more
wiley   +1 more source

Adamantinoid Basal Cell Carcinoma: Clinical, Histological and Dermoscopic Findings. [PDF]

Clin Case Rep
Furudate S, Nakagawa H, Asano Y.
europepmc   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

A Presentation of Fungating Nevoid Basal Cell Carcinoma Syndrome. [PDF]

Cureus
Ogunremi OO, Hannahs B, Hockhausen K.
europepmc   +1 more source

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira, Anna Skwarska, Karolina Chwialkowska, Agnieszka Ostrowska, Gabriela Sokolowska, Anna Zeller, Anna Erol, Andrzej Eljaszewicz, Bartosz Hanczaruk, Anna Michalska‐Falkowska, Agnieszka Tarasik, Joanna Reszec‐Gielazyn, Pawel Knapp, Marcin Moniuszko, Adam Kretowski   +14 more
wiley   +1 more source

Does Basal Cell Carcinoma Arise from a Precursor Lesion? [PDF]

J Invest Dermatol
Wong SY, Harms PW, Dlugosz AA.
europepmc   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source

Streamlined Management of Basal Cell Carcinoma with Dermoscopy: A Retrospective Case-Control Study. [PDF]

J Clin Med
Donoso F, Aguero R, Caussade MC, Peirano D, Hidalgo L, Villagrán S, De Amesti P, Meza V, Hasenberg J, Droppelmann K, Abarzúa-Araya Á, Camilo Castro-Ayala J, Paoli J, Uribe P, Navarrete-Dechent C.   +14 more
europepmc   +1 more source

Advancing Pyrogen Testing for Vaccines with Inherent Pyrogenicity: Development of a Novel Reporter Cell-Based Monocyte Activation Test (MAT) [PDF]

Shuhua Yi, Jenny Xu, Liping Song, Frank Celeste, Christopher J. Wang, Melissa C. Whiteman   +5 more
openalex   +1 more source